-
Ginsenoside Rh2-Based Multifunctional Liposomes for Advanced Breast Cancer Therapy
19 Mar 2024 14:20 GMT
… established a large breast tumor model to evaluate … breast cancer, we selected two commercially available PTX nano-formulations, Lipusu® and Abraxane®. Abraxane … Although only 4T1 breast tumors were tested as … of triple-negative breast cancer by ginsenoside …
-
Nanoparticles for the Treatment of Bone Metastasis in Breast Cancer: Recent Advances and Challenges
23 Feb 2024 13:20 GMT
… and cisplatin to breast tumors and showed promising … colonization of disseminated breast tumor cells in the bone … . Targeting of primary breast cancers and metastases in a … (Abraxane) in combination with gemcitabine in patients with metastatic breast cancer …
-
Tinengotinib exhibits activity in pretreated breast cancer
20 Jan 2024 12:39 GMT
… Abraxane, Bristol Myers Squibb) — appeared manageable, researchers reported at San Antonio Breast Cancer … HER2-ngative breast cancer or triple-negative breast cancer who had no … patients with triple-negative breast cancer exhibited stable disease. Researchers …
-
Paclitaxel albumin bound by Bristol-Myers Squibb for Gallbladder Cancer: Likelihood of Approval
18 Apr 2024 03:41 GMT
… bound overview
Paclitaxel (Abraxane, Abraxus ABI-007) … Abraxane is indicated for the treatment of metastatic breast cancer … cancer, metastatic triple negative breast cancer, peritoneal cancer, pancreatic … cancer, HER2 positive breast cancer, small cell lung …
-
Global Breast Cancer Immunotherapy Market Size Clinical Trials Insight
26 Jun 2023 10:16 GMT
… impact in the treatment of breast cancer. Traditionally, breast cancer has been treated by … positive metastatic triple negative breast cancer in combination with abraxane under accelerated approval …
-
Toripalimab regimen delays progression of PD-L1-positive triple-negative breast cancer
05 Jun 2023 01:09 GMT
… -line treatment for triple-negative breast cancer. Toripalimab [Junshi Biosciences], a humanized … plus first-line nab-paclitaxel (Abraxane, Bristol Myers Squibb) vs. … or recurrent inoperable triple-negative breast cancer.
Researchers assigned patients 2:1 …
-
De-Escalation Has Lasting Benefits for HER2+ Breast Cancers
05 Apr 2023 15:36 GMT
… treatment with paclitaxel (Abraxane) and trastuzumab (Herceptin … certain HER2-positive breast cancers. Few distant recurrences … Side Effects
HER2-positive breast cancers, which are characterized … characteristics of HER2-positive breast cancer, and the prognosis …
-
What medications are available to treat breast cancer?
31 Jan 2023 19:23 GMT
… .
For hormone receptor-negative breast cancer, or triple-negative breast cancer, hormone therapy and … :
docetaxel
paclitaxel
albumin-bound paclitaxel (Abraxane)
anthracyclines, including:
doxorubicin
liposomal doxorubicin …
-
Infinity Pharmaceuticals Provides MARIO-3 Update in Patients with Front Line Metastatic Triple Negative Breast Cancer Suggesting Potential Long-Term Patient Benefit of Eganelisib
14 Nov 2022 12:52 GMT
… front-line metastatic triple negative breast cancer (TNBC) patients.
“Given … since the San Antonio Breast Cancer Symposium 2021, there is … combination with Tecentriq® and Abraxane® in front-line … trademark of Genentech, Inc.
Abraxane® is a registered trademark …
-
Pembrolizumab plus chemotherapy extends survival in triple-negative breast cancer subset
21 Jul 2022 18:05 GMT
… continued improvement of breast cancer treatment.”
The addition … metastatic triple-negative breast cancer, according to study … including nab-paclitaxel (Abraxane, Celgene), paclitaxel or … continued improvement of breast cancer treatment. Other immunotherapies …